Tim Lu takes Senti and its gene circuit tech public in $296M deal riding on Omid Farokhzad’s SPAC

Omid Farokhzad

Omid Farokhzad didn’t have to travel far to find a private biotech he wanted to take public with his $200 million blank-check company.

Senti Bio — the synthetic biology play launched and now helmed by MIT whiz Tim Lu — will be merging…